Heinz-Josef Lenz
机构: University of Southern Califfornia
每年引用次数
引用次数
引用: 85,007
H-指数: 123
I10-指数 : 635
出版物: 1,649
High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with nonresponse to 5-fluorouracil.
P V Danenberg , H J Lenz , D Salonga , S Groshen
Clinical Cancer Research 4 ( 10) 2371 -2376
306
1998
Neurohormonal relations between brain and gastrointestinal tract
H J Lenz
Medizinische Klinik 81 ( 21) 676 -680
1986
Correction to: KSR1 regulates BRCA1 degradation and inhibits breast cancer growth.
G Giamas , L C Lit , L C Lit , A R Green
Oncogene 40 ( 19) 3473 -3473
2021
Gender-specific profiling in SCN1A polymorphisms and time-to-recurrence in patients with stage II/III colorectal cancer treated with adjuvant 5-fluoruracil chemotherapy
L Benhaim , A Gerger , P Bohanes , D Paez
Pharmacogenomics Journal 14 ( 2) 135 -141
9
2014
Genetic variants of kinase suppressors of Ras (KSR1) to predict survival in patients with ERα-positive advanced breast cancer
L Benhaim , W Zhang , T Wakatsuki , D Yang
Pharmacogenomics Journal 15 ( 3) 235 -240
2015
Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival.
H J Lenz , C G Leichman , K D Danenberg , P V Danenberg
Journal of Clinical Oncology 14 ( 1) 176 -182
462
1996
Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin.
C G Leichman , H J Lenz , L Leichman , K Danenberg
Journal of Clinical Oncology 15 ( 10) 3223 -3229
454
1997
ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy.
R Metzger , C G Leichman , K D Danenberg , P V Danenberg
Journal of Clinical Oncology 16 ( 1) 309 -316
459
1998
KSR1 regulates BRCA1 degradation and inhibits breast cancer growth
J Stebbing , H Zhang , Y Xu , L C Lit
Oncogene 34 ( 16) 2103 -2114
10
2015
Rapid quantitative PCR for determination of relative gene expressions in tissue specimens.
H J Lenz , C Hill , K D Danenberg , L L Leichman
Genome Research 4 ( 5) 305 -308
8
1995
Intercellular Communication Mediates the Bystander Effect During Herpes Simplex Thymidine Kinase/Ganciclovir-Based Gene Therapy of Human Gastrointestinal Tumor Cells
Lily Yang , Yawen Chiang , Heinze-Josef Lenz , Kathleen D. Danenberg
Human Gene Therapy 9 ( 5) 719 -728
87
1998
MINDFULNESS AND DEPRESSIVE AND PHYSICAL SYMPTOMS AMONG PATIENTS WITH METASTATIC COLORECTAL CANCER
Heinz-Joseph Lenz , Taline Khoukaz , Megan Taylor-Ford , Anthony El-Khoueiry
Annals of Behavioral Medicine 47
2014
920 Addition of Algenpantucel-L Immunotherapy to Standard Adjuvant Therapy for Pancreatic Cancer: A Phase 2 Study
Jeffrey M. Hardacre , Mary Mulcahy , William Small , Mark Talamonti
Gastroenterology 142 ( 5)
5
2012
Mo2076 SNP Array 6.0 Analysis in Advanced Gastric Cancer Patients Treated With 5-FU and Platinum or Irinotecan Based Chemoradiation
Peter P. Grimminger , Martin K. Maus , Frederick Schumacher , Ralf Metzger
Gastroenterology 142 ( 5)
2012
Priorities in colorectal cancer research: recommendations from the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative Groups.
Peter J. O'Dwyer , S. Gail Eckhardt , Daniel G. Haller , Joel Tepper
Journal of Clinical Oncology 25 ( 16) 2313 -2321
20
2007
Extended safety and efficacy data on S-1 plus cisplatin in patients with untreated, advanced gastric carcinoma in a multicenter phase II study
Heinz-Joseph Lenz , Fa-Chyi Lee , Daniel G. Haller , Deepti Singh
Cancer 109 ( 1) 33 -40
50
2007
Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor‐bearing microparticles: a randomized‐controlled phase II trial (the Microtec study)
Jeffrey I. Zwicker , Howard A. Liebman , Kenneth A. Bauer , Thomas Caughey
British Journal of Haematology 160 ( 4) 530 -537
106
2013
Addition of Algenpantucel-L Immunotherapy to Standard Adjuvant Therapy for Pancreatic Cancer: A Phase 2 Study
Jeffrey M. Hardacre , Mary Mulcahy , William Small , Mark Talamonti
Journal of Gastrointestinal Surgery 17 ( 1) 94 -101
118
2013
Multi-Center Phase II Trial of Temsirolimus (TEM) and Bevacizumab (BEV) in Pancreatic Neuroendocrine Tumor (PNET): results of a planned interim efficacy analysis
Timothy Hobday , Rui Qin , Diane Reidy , Malcolm Moore
Pancreas 42 ( 2) 375 -376
1
2013
Eastern Cooperative Oncology Group
Heinz-Joseph Lenz
2010
WU ZHANG Alfredo Falcone Francesca Battaglin Axel Grothey Shivani Soni Fotios Loupakis Martin D. Berger Howard S. Hochster Alberto Puccini Federico Innocenti Georg Lurje Salvatore Siena Scott Kopetz Yu Sunakawa Thierry André Bert O'Neil Armin Gerger chiara cremolini Anthony El-Khoueiry Fortunato Ciardiello